Chartwell Investment Partners LLC raised its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 3.8% in the 1st quarter, HoldingsChannel.com reports. The firm owned 28,797 shares of the company’s stock after purchasing an additional 1,048 shares during the period. Chartwell Investment Partners LLC’s holdings in Henry Schein were worth $1,731,000 as of its most recent filing with the SEC.
Other institutional investors have also made changes to their positions in the company. Financial Gravity Companies Inc. purchased a new stake in shares of Henry Schein in the fourth quarter worth about $29,000. Bruderman Asset Management LLC purchased a new stake in Henry Schein during the fourth quarter valued at approximately $39,000. Ipswich Investment Management Co. Inc. purchased a new stake in Henry Schein during the fourth quarter valued at approximately $45,000. Howe & Rusling Inc. raised its position in Henry Schein by 200.0% during the fourth quarter. Howe & Rusling Inc. now owns 600 shares of the company’s stock valued at $47,000 after purchasing an additional 400 shares during the period. Finally, Essex Savings Bank purchased a new stake in Henry Schein during the fourth quarter valued at approximately $48,000.
In other Henry Schein news, Director Philip A. Laskawy sold 3,591 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $59.12, for a total transaction of $212,299.92. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Philip A. Laskawy sold 1,084 shares of the stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $59.86, for a total value of $64,888.24. Following the sale, the director now directly owns 32,899 shares in the company, valued at $1,969,334.14. The disclosure for this sale can be found here. Company insiders own 1.15% of the company’s stock.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Wednesday, February 20th. The company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.11 by $0.01. Henry Schein had a return on equity of 19.86% and a net margin of 4.06%. The firm had revenue of $3.38 billion during the quarter, compared to analyst estimates of $3.46 billion. During the same quarter in the prior year, the business posted $0.97 EPS. The business’s revenue for the quarter was up 1.7% compared to the same quarter last year. Analysts forecast that Henry Schein, Inc. will post 3.43 earnings per share for the current year.
A number of research analysts have recently commented on HSIC shares. Barclays cut their target price on Henry Schein from $73.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 21st. Zacks Investment Research cut Henry Schein from a “hold” rating to a “sell” rating in a research note on Tuesday, February 26th. UBS Group initiated coverage on Henry Schein in a research note on Thursday, January 17th. They issued a “sell” rating and a $73.00 price objective on the stock. BidaskClub cut Henry Schein from a “hold” rating to a “sell” rating in a research note on Tuesday, January 29th. Finally, ValuEngine raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Monday, February 4th. Seven analysts have rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $79.87.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Article: Compound Annual Growth Rate (CAGR)
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.